Shape Therapeutics

About:

A biotechnology company developing RNA technologies to shape the future of gene therapy

Website: https://www.shapetx.com/

Twitter/X: ShapeTx

Top Investors: New Enterprise Associates, Mission BioCapital, Decheng Capital, Willett Advisors LLC, Breton Capital Management

Description:

Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.

Total Funding Amount:

$148M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2018-04-05

Contact Email:

info(AT)shapetx.com

Founders:

Francois Vigneault, John Suliman, Prashant Mali

Number of Employees:

101-250

Last Funding Date:

2021-07-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai